Dr. Yudkoff is a board-certified psychiatrist who provides the most up-to-date psychiatric care to people managing illnesses that have not satisfactorily resolved with treatment as usual, and in a way which honors principles of autonomy, self-direction, and holistic approaches. He has lectured on spirituality and ketamine, is an Instructor in Psychiatry at Harvard Medical School, and has taught a humanism course to residents of the Harvard Brigham and Women’s Hospital Residency Training Program. Dr. Yudkoff has served as the Medical Director of the Brigham and Women’s Faulkner Hospital and the Medical Director of the Interventional Psychiatric Service (electroconvulsive therapy, ketamine, and esketamine). Dr. Yudkoff has published scientific articles on ketamine and psychopharmacology, and has won several teaching awards from Harvard Medical School students and Brigham and Women’s Psychiatric Residents. His recent peer-reviewed work includes “What matters in next-generation implanted neurotechnology design? Perspectives from individuals with treatment-refractory depression” (Journal of Neural Engineering, 2026) and “Empowering understanding: navigating consent to ketamine treatment in adolescent mental health” (Frontiers in Psychiatry, 2024), co-authored with Lumin Health’s Dr. Aakash Sathappan.
